Related Experiment Video
Updated: Jun 26, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Tuberculosis elimination in the Canadian First Nations population: assessment by a state-transfer, compartmental
Michael Clark1, D William Cameron
1Department of Pediatrics, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, Ontario, K1H 8L1, Canada. mclar018@uottawa.ca
Background:
Tuberculosis (TB) remains an important public health problem in Canadian Aboriginal (First Nations and Inuit) communities. The objectives of this study were to predict future disease burden and set feasible targets for the elimination of TB in the First Nations population, using retrospective data and an epidemic model.
Methods:
Reported TB incidence data (1974-2002), previously published TB meningitis data from the pre-chemotherapy era, and previous estimates of disease risk following infection were used to estimate a trend in the annual risk of infection from 1929 to 2002, and the age-specific prevalence of infection in 2002. A state-transfer, compartmental model was then developed to predict future disease burden. Two scenarios were simulated, with different disease risk parameters.
Results:
The estimated prevalence of infection in 2002 was 20.9% in scenario 1 and 25.5% in scenario 2. Predicted incidence rates in 2015 were 16.8 per 100,000 and 11.7 per 100,000 for the two scenarios, respectively. The incidence of disease was not lower than 1 per 100,000 for either scenario in 2034, the arbitrarily chosen last year of the model.
Conclusions:
The goal of eliminating TB among Aboriginal peoples in Canada is a feasible one, but will only be achieved with continued investment in programs designed to control and prevent transmission. Reactivation disease cases may occur for a number of years to come, making rapid elimination a difficult goal.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: